Applied BioCode Corp
TWSE:6598
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| TW |
|
Applied BioCode Corp
TWSE:6598
|
2.5B TWD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
188.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.1B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
139.2B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.6B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
111.9B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.3B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.4B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -22 082.4% |
| 30th Percentile | 1% |
| Median | 5.3% |
| 70th Percentile | 11.1% |
| Max | 1 580% |
Other Profitability Ratios
Applied BioCode Corp
Glance View
Applied BioCode Corp. designs, develops, manufactures and commercializes multiplex testing products for in-vitro diagnostics market. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-02-09. The firm's main products include digital barcode magnetic beads (BMB), optical analyzers, in vitro diagnostic reagents and others. The firm sells in the United States, Europe and Asia markets.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Applied BioCode Corp is -46.9%, which is above its 3-year median of -51.1%.
Over the last 3 years, Applied BioCode Corp’s Net Margin has decreased from -46.2% to -46.9%. During this period, it reached a low of -76% on Dec 31, 2024 and a high of -38.6% on Mar 31, 2023.
